secwatch / observer
8-K filed March 27, 2024, 7:59 PM ET ticker CSTL CIK 0001447362
other material confidence high sentiment neutral materiality 0.55

Castle Biosciences secures $35M SVB loan facility; appoints Rodney Cotton to board

CASTLE BIOSCIENCES INC

item 1.01item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mara G. Aspinall

Director
CSTL · CASTLE BIOSCIENCES INC
Filed
March 27, 2024, 7:59 PM ET
On March 26, 2024, Mara G. Aspinall notified the Company that she will not to stand for re-election to the board of directors (the “Board”) of the Company at the expiration of her current term at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).
Appointed

Rodney Cotton

Class II Director
CSTL · CASTLE BIOSCIENCES INC
Effective
2024-03-26
Filed
March 27, 2024, 7:59 PM ET
On March 26, 2024, following the recommendation of the nominating and corporate governance committee of the Board, the Board increased the size of the Board from eight to nine members and appointed Rodney Cotton to serve as a Class II director with a term ending at the 2024 Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mara G. Aspinall departed as Director at CASTLE BIOSCIENCES INC.

Action
not to stand for re-election
Role
Director
Exact text from the filing
On March 26, 2024, Mara G. Aspinall notified the Company that she will not to stand for re-election to the board of directors (the “Board”) of the Company at the expiration of her current term at the Company’s 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Rodney Cotton was appointed as Class II Director at CASTLE BIOSCIENCES INC.

Action
appointed
Role
Class II Director
Exact text from the filing
On March 26, 2024, following the recommendation of the nominating and corporate governance committee of the Board, the Board increased the size of the Board from eight to nine members and appointed Rodney Cotton to serve as a Class II director with a term ending at the 2024 Annual Meeting.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CASTLE BIOSCIENCES INC entered into Loan and Security Agreement with Silicon Valley Bank, a division of First-Citizens Bank & Trust Company valued at $10.0 million aggregate principal amount of term loans (effective 2024-03-26).

Action
entry
Agreement
credit facility
Counterparty
Silicon Valley Bank, a division of First-Citizens Bank & Trust Company
Value
$10.0 million aggregate principal amount of term loans
Effective
2024-03-26
Exact text from the filing
On March 26, 2024 (the “Closing Date”), Castle Biosciences, Inc., a Delaware corporation (the “Company”), entered into a Loan and Security Agreement (the “Loan Agreement”), by and between the Company, its wholly owned subsidiary, Castle Narnia Real Estate Holding 1, LLC (“Narnia”) and Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (the “Lender”).
View on SEC.gov

419 material agreements filed in the last 30 days. Browse all material agreements →

CASTLE BIOSCIENCES INC filing history →

Source: SEC EDGAR
accession 0001193125-24-078933
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.